首页>
中文期刊>
《国际转化医学杂志（英文版）》
>Effect of Hematodialysis plus Hemoperfusion on Insulin Resistance and Nutritional Status of Patients with End-Stage Diabetic Nephropathy
Effect of Hematodialysis plus Hemoperfusion on Insulin Resistance and Nutritional Status of Patients with End-Stage Diabetic Nephropathy
Objective: To explore the effect of hematodialysis (HD) combined with hemoperfusion (HP) on the insulin resistance (IR) and nutritional status of patients with end-stage diabetic nephropathy (ESDN). Methods: Eighty-six patients with ESDN were randomly divided into group A (n=28), group B (n=30) and group C (n=28), and another 24 healthy volunteers were selected as control group. Groups A, B and C were respectively treated with routine HD, HD combined with hemodiaifltration (HDF) as well as and HD combined with HP. The levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) as well as the changes of ureanitrogen (BUN), creatinine (Scr), fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (Homa-IR), hemoglobin (Hb), albumin (Alb) and body mass index (BMI) were compared among groups before and 12 weeks after treatment. Results: 12 weeks after treatment, the levels of CRP, TNF-α and IL-6 in group A did not change obviously, whereas those in groups B and C decreased dramatically when compared with treatment before (P0.05). Compared with treatment before, FBG and FINS levels as well as Homa-IR reduced (P0.05). FBG, FINS and Homa-IR were all lower, but Hb, Alb and BMI were markedly higher in group C than in groups A and B 12 weeks after treatment, and signiifcant differences were shown (P<0.05 orP<0.01). Conclusion:HD combined with HP can effectively remove the mid- and macro-molecular inlfammatory mediators alleviate IR and ameliorate the nutritional status to reduce the incidence of malnutrition in the patients with ESDN.
展开▼
